Literature DB >> 23317655

Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration.

Jae Hui Kim1, Jae Ryung Kim, Se Woong Kang, Sang Jin Kim, Hyo Shin Ha.   

Abstract

PURPOSE: To compare choroidal thickness and extent and density of drusen between eyes with typical exudative age-related macular degeneration (AMD) and eyes with retinal angiomatous proliferation (RAP).
DESIGN: Observational case series.
METHODS: Twenty-four eyes with typical exudative AMD and 20 eyes with RAP were included. Subfoveal choroidal thickness was measured using enhanced depth imaging optical coherence tomography. Eyes were classified into 3 groups according to the extent of drusen distribution in the fundus photograph. Density of drusen was estimated based on optical coherence tomography images of the fellow eye. The proportion of the length beneath the drusen per the entire length of the Bruch membrane was defined as the density of drusen. Subfoveal choroidal thickness, extent of drusen distribution, and the density of drusen were compared between typical exudative AMD and RAP.
RESULTS: Mean ± standard deviation subfoveal choroidal thickness in eyes with typical exudative AMD and eyes with RAP was 184.9 ± 68.5 μm and 139.0 ± 65.5 μm, respectively (P = .035). The mean density of drusen was 0.06 ± 0.08 and 0.24 ± 0.12, respectively (P < .001). In the typical exudative AMD group, 19, 3, and 2 eyes were included in the small extent group (<one third), intermediate extent group (one third to two thirds), and large extent group (>two thirds), respectively. In the RAP group, 3, 14, and 3 eyes were included in each aforementioned group, respectively (P = .001).
CONCLUSIONS: The thinner subfoveal choroidal thickness and greater extent and density of drusen in RAP than the typical exudative AMD may suggest compromised choroidal perfusion in the development of RAP.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23317655     DOI: 10.1016/j.ajo.2012.11.001

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  22 in total

1.  Re: Cho et al. "Long-term visual outcome and prognostic factors of intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation".

Authors:  Akin Cakir; Eyup Duzgun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-21       Impact factor: 3.117

2.  Pseudodrusen pattern and development of late age-related macular degeneration in the fellow eye of the unilateral case.

Authors:  Yoichi Sakurada; Atsushi Sugiyama; Wataru Kikushima; Seigo Yoneyama; Naohiko Tanabe; Mio Matsubara; Hiroyuki Iijima
Journal:  Jpn J Ophthalmol       Date:  2019-07-02       Impact factor: 2.447

3.  Ocular changes in TgF344-AD rat model of Alzheimer's disease.

Authors:  Yuchun Tsai; Bin Lu; Alexander V Ljubimov; Sergey Girman; Fred N Ross-Cisneros; Alfredo A Sadun; Clive N Svendsen; Robert M Cohen; Shaomei Wang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

4.  Long-term visual outcome and prognostic factors of Intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation.

Authors:  Han Joo Cho; Tae Gon Lee; Sang Youn Han; Hyoung Seok Kim; Jae Hui Kim; Jung Il Han; Young Ju Lew; Jong Woo Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-01       Impact factor: 3.117

5.  Quantitative assessment of choriocapillaris flow deficits in eyes with macular neovascularization.

Authors:  Federico Corvi; Mariano Cozzi; Giulia Corradetti; Giovanni Staurenghi; David Sarraf; SriniVas R Sadda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-08       Impact factor: 3.117

Review 6.  Association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis.

Authors:  Mohammad Hossein Jabbarpoor Bonyadi; Mehdi Yaseri; Mortaza Bonyadi; Masoud Soheilian
Journal:  Int Ophthalmol       Date:  2016-12-22       Impact factor: 2.031

7.  Age-related differences in the prevalence of subtypes of Neovascular age-related macular degeneration in the first diagnosed eye.

Authors:  Jae Hui Kim; Young Suk Chang; Jong Woo Kim; Chul Gu Kim; Dong Won Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-07       Impact factor: 3.117

8.  Clinical features associated with the atrophy of fellow eyes in patients with unilateral type 3 macular neovascularization.

Authors:  Mihyun Choi; Eun Gyu Yoon; Ki Tae Nam; Cheolmin Yun
Journal:  Int Ophthalmol       Date:  2022-09-04       Impact factor: 2.029

9.  Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related macular degeneration.

Authors:  Seigo Yoneyama; Yoichi Sakurada; Fumihiko Mabuchi; Mitsuhiro Imasawa; Atsushi Sugiyama; Takeo Kubota; Hiroyuki Iijima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-05       Impact factor: 3.117

10.  Unaffected fellow eye neovascularization in patients with type 3 neovascularization: Incidence and risk factors.

Authors:  Jae Hyuck Kwak; Woo Kyung Park; Rae Young Kim; Mirinae Kim; Young-Gun Park; Young-Hoon Park
Journal:  PLoS One       Date:  2021-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.